Projects overview

Sort by


Toggle all information

STARS | Strengthening training of academia in regulatory sciences and supporting regulatory scientific advice (STARS)

01-01-2019

-

30-06-2022

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.6. Health care provision and integrated care
H2020-EU.3.1.6.0. Cross-cutting call topics
H2020-SC1-2018-Single-Stage-RTD
SC1-HCO-05-2018 Strengthening regulatory sciences and supporting regulatory scientific advice

PERMIT | PERsonalised MedicIne Trials

01-01-2020

-

30-06-2022

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.6. Health care provision and integrated care
H2020-EU.3.1.6.0. Cross-cutting call topics
H2020-SC1-2018-Single-Stage-RTD
SC1-HCO-01-2018-2019-2020 Actions in support of the International Consortium for Personalised Medicine
H2020-SC1-2019-Single-Stage-RTD
SC1-HCO-01-2018-2019-2020 Actions in support of the International Consortium for Personalised Medicine

INCAREHEART | Pre-commercial Procurement of innovative ICT-enabled integrated care solutions to advance multidisciplinary health and care for patients with chronic heart failure

01-02-2021

-

31-03-2025

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.0. Cross-cutting call topics
H2020-SC1-2020-Single-Stage-RTD
SC1-BHC-20A-2020 Pre-commercial procurement (PCP) for integrated care solutions

ERGO | Breaking down the wall between human health and environmental testing of endocrine disrupters: EndocRine Guideline Optimisation

01-01-2019

-

30-06-2024

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.1. Understanding health, wellbeing and disease
H2020-SC1-2018-Single-Stage-RTD
SC1-BHC-27-2018 New testing and screening methods to identify endocrine disrupting chemicals

CIRDvalid | CIRDvalid – Clinical validation of a set of 11 biomarkers and a system of diagnostic and therapeutical devices for the resuscitation of patients suffering from long-lasting cardiac arrest

01-06-2015

-

30-09-2015

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-SMEINST-1-2015
PHC-12-2015-1 Clinical research for the validation of biomarkers and/or diagnostic medical devices

BornToGetThere | Implementation of early detection and early intervention service delivery in infants at risk for cerebral palsy to promote infants’ psychomotor development and maternal health

01-01-2020

-

31-12-2024

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.6. Health care provision and integrated care
H2020-EU.3.1.6.0. Cross-cutting call topics
H2020-SC1-2019-Two-Stage-RTD
SC1-BHC-19-2019 Implementation research for maternal and child health

REGIONS4PERMED | INTERREGIONAL COORDINATION FOR A FAST AND DEEP UPTAKE OF PERSONALISED HEALTH

01-11-2018

-

30-04-2023

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.6. Health care provision and integrated care
H2020-EU.3.1.6.0. Cross-cutting call topics
H2020-SC1-2018-Single-Stage-RTD
SC1-HCO-01-2018-2019-2020 Actions in support of the International Consortium for Personalised Medicine
H2020-SC1-2019-Single-Stage-RTD
SC1-HCO-01-2018-2019-2020 Actions in support of the International Consortium for Personalised Medicine

QSPainRelief | Effective combinational treatment of chronic pain in individual patients, by an innovative quantitative systems pharmacology pain relief approach.

01-01-2020

-

30-06-2025

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.1. Understanding health, wellbeing and disease
H2020-SC1-2019-Two-Stage-RTD
SC1-BHC-02-2019 Systems approaches for the discovery of combinatorial therapies for complex disorders

miniNO | Associative mechanisms linking a defective minipuberty to the appearance of mental and nonmental disorders: infantile NO replenishment as a new therapeutic possibility

01-01-2020

-

31-12-2025

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.1. Understanding health, wellbeing and disease
H2020-SC1-2019-Two-Stage-RTD
SC1-BHC-01-2019 Understanding causative mechanisms in co- and multimorbidities combining mental and non-mental disorders

SAPHIRE | Securing Adoption of Personalised Health in REgions

01-12-2018

-

31-05-2022

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.6. Health care provision and integrated care
H2020-EU.3.1.6.0. Cross-cutting call topics
H2020-SC1-2018-Single-Stage-RTD
SC1-HCO-01-2018-2019-2020 Actions in support of the International Consortium for Personalised Medicine
H2020-SC1-2019-Single-Stage-RTD
SC1-HCO-01-2018-2019-2020 Actions in support of the International Consortium for Personalised Medicine

ANDROTEST | Point of care test for non invasive differential diagnosis of obstrutive and non-obstructive azoospermia in male fertility

01-07-2015

-

31-10-2015

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-SMEINST-1-2015
PHC-12-2015-1 Clinical research for the validation of biomarkers and/or diagnostic medical devices

DiaChemo | Point-of-care microfluidic device for quantification of chemotherapeutic drugs in small body fluid samples by highly selective nanoparticle extraction and liquid crystal detection

01-05-2015

-

31-10-2020

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-PHC-2014-two-stage
PHC-10-2014 Development of new diagnostic tools and technologies: in vitro devices, assays and platforms

AUTOSTEM | Development of closed, scalable and AUTOmated robotic systems for therapeutic STEM cell manufacturing: aseptic systems from “Donor-to-Patient”

01-01-2016

-

31-12-2018

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-PHC-2015-two-stage
PHC-16-2015 Tools and technologies for advanced therapies

t-Clinic | An innovative medical device for early diagnosis based on a disruptive body temperature monitoring and analysis scheme-t-Clinic

01-04-2016

-

30-09-2016

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-SMEINST-1-2015
PHC-12-2015-1 Clinical research for the validation of biomarkers and/or diagnostic medical devices

VasQ | An innovative external brace to ensure patency and maturity of arteriovenous fistulas in haemodialysis patients.

01-12-2015

-

31-03-2016

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-SMEINST-1-2015
PHC-12-2015-1 Clinical research for the validation of biomarkers and/or diagnostic medical devices

SMART BEAR | Smart Big Data Platform to Offer Evidence-based Personalised Support for Healthy and Independent Living at Home

01-09-2019

-

28-02-2025

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.4. Active ageing and self-management of health
H2020-EU.3.1.4.1. Active ageing, independent and assisted living
H2020-SC1-FA-DTS-2018-2
DT-TDS-01-2019 Smart and healthy living at home

StableVax | Commercialisation of a world changing invention for the stabilisation and delivery of vaccines

01-09-2015

-

31-10-2015

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-SMEINST-1-2015
PHC-12-2015-1 Clinical research for the validation of biomarkers and/or diagnostic medical devices

Safe Gestation | Feasibility study for clinical validation of NTproCNP as a novel biomarker for pregnancy complications

01-07-2015

-

31-10-2015

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-SMEINST-1-2015
PHC-12-2015-1 Clinical research for the validation of biomarkers and/or diagnostic medical devices

POC products | A novel microfluid-based modular system to address POC challenges within the field of coagulation and hemostasis

01-07-2015

-

31-12-2015

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-SMEINST-1-2015
PHC-12-2015-1 Clinical research for the validation of biomarkers and/or diagnostic medical devices

AntibioDx | AntibioDx: A groundbreaking in vitro diagnostic device with a billion-dollar sales potential

01-09-2015

-

29-02-2016

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-SMEINST-1-2015
PHC-12-2015-1 Clinical research for the validation of biomarkers and/or diagnostic medical devices
Powered by Chris Decubber BV